P

Inventor

OESTERGAARD MICHAEL

US20 patents
⚠️ This page may combine multiple inventors who share the name “OESTERGAARD MICHAEL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

IONIS PHARMACEUTICALS INC

17 patents
US11236335B2Feb 1, 2022

Selective antisense compounds and uses thereof

IONIS PHARMACEUTICALS INC6 citations86
US10260069B2Apr 16, 2019

Selective antisense compounds and uses thereof

IONIS PHARMACEUTICALS INC10 citations84
US11149264B2Oct 19, 2021

Modified compounds and uses thereof

IONIS PHARMACEUTICALS INC5 citations83
US10344275B2Jul 9, 2019

Linkage modified oligomeric compounds

IONIS PHARMACEUTICALS INC8 citations83
US11732261B2Aug 22, 2023

Selective antisense compounds and uses thereof

IONIS PHARMACEUTICALS INC2 citations73
US11116843B2Sep 14, 2021

Conjugated antisense compounds and their use

IONIS PHARMACEUTICALS INC3 citations73
US11332733B2May 17, 2022

Modified compounds and uses thereof

IONIS PHARMACEUTICALS INC4 citations72
US9926556B2Mar 27, 2018

Linkage modified oligomeric compounds

IONIS PHARMACEUTICALS INC5 citations72
US11629348B2Apr 18, 2023

Linkage modified oligomeric compounds and uses thereof

IONIS PHARMACEUTICALS INC2 citations69
US12234447B2Feb 25, 2025

Modified compounds and uses thereof

IONIS PHARMACEUTICALS INC0 citations62
US12152244B2Nov 26, 2024

Selective antisense compounds and uses thereof

IONIS PHARMACEUTICALS INC0 citations62
US12275940B2Apr 15, 2025

Conjugated antisense compounds and their use

IONIS PHARMACEUTICALS INC0 citations60
US11725208B2Aug 15, 2023

Conjugated antisense compounds and their use

IONIS PHARMACEUTICALS INC1 citations60
US12595482B2Apr 7, 2026

Linkage modified oligomeric compounds and uses thereof

IONIS PHARMACEUTICALS INC0 citations58
US11180756B2Nov 23, 2021

Morpholino modified oligomeric compounds

IONIS PHARMACEUTICALS INC0 citations52
US10865413B2Dec 15, 2020

Oligomeric compounds comprising α-β-constrained nucleic acid

IONIS PHARMACEUTICALS INC0 citations52
US10221416B2Mar 5, 2019

Oligomeric compounds comprising alpha-beta-constrained nucleic acid

IONIS PHARMACEUTICALS INC0 citations52

SETH PUNIT P

1 patent

OESTERGAARD MICHAEL

1 patent

UNIV CALIFORNIA

1 patent